Modeling and Simulation Guides Dosing for a New Anti-psychotic Drug Blog Modeling and Simulation Guides Dosing for a New Anti-psychotic Drug Drug development is becoming more complex than ever. Regulatory agencies expect sponsors to consider a…Certara2016 年 10 月 21 日
Certara Establishes Phoenix PK/PD Centers of Excellence in China and Japan Press Release Certara Establishes Phoenix PK/PD Centers of Excellence in China and Japan PRINCETON, NJ – Oct. 13, 2016 – Certara, the leading provider of decision support technology…Certara2016 年 10 月 13 日
Kelley Kendle, President of Certara’s Synchrogenix Division, Named to DBT ‘Top 40 Under 40’ Press Release Kelley Kendle, President of Certara’s Synchrogenix Division, Named to DBT ‘Top 40 Under 40’ PRINCETON, NJ – Oct. 6, 2016 – Certara announces that Kelley Kendle, president of Synchrogenix,…Certara2016 年 10 月 6 日
Profiling the Relationship Between Tumor-associated Macrophages and Pharmacokinetics of Liposomal Agents in Preclinical Murine Models Publication Profiling the Relationship Between Tumor-associated Macrophages and Pharmacokinetics of Liposomal Agents in Preclinical Murine Models Certara2016 年 10 月 5 日
A Study to Examine the Relationship Between Metritis Severity and Depletion of Oxytetracycline in Plasma and Milk after Intrauterine Infusion Publication A Study to Examine the Relationship Between Metritis Severity and Depletion of Oxytetracycline in Plasma and Milk after Intrauterine Infusion Metritis is a frequent problem in postpartum dairy cows. Intrauterine therapy with the antimicrobial oxytetracycline…Certara2016 年 10 月 1 日
Gulp1 is Associated with the Pharmacokinetics of PEGylated Liposomal Doxorubicin (PLD) in Inbred Mouse Strains Publication Gulp1 is Associated with the Pharmacokinetics of PEGylated Liposomal Doxorubicin (PLD) in Inbred Mouse Strains Certara2016 年 10 月 1 日
FDA’s New Module 1 is a Bridge to eCTD 4 Blog FDA’s New Module 1 is a Bridge to eCTD 4 Editor’s note: Jason Rock served as Project Lead for the HL7 RCRIM Expert Working Group…Certara2016 年 9 月 13 日
Arming Adherence-based Drug Development with Pharmacometrics Blog Arming Adherence-based Drug Development with Pharmacometrics The time is right to explore how sensor-enabled digital adherence monitoring systems can benefit patients,…Certara2016 年 9 月 12 日
The Role of a U.S. Agent Blog The Role of a U.S. Agent Foreign sponsors of drug applications who want to conduct business in the United States need…Certara2016 年 9 月 6 日
Bacterial Loads Measured by the Xpert MTB/RIF Assay as Markers of Culture Conversion and Bacteriological Cure in Pulmonary TB Publication Bacterial Loads Measured by the Xpert MTB/RIF Assay as Markers of Culture Conversion and Bacteriological Cure in Pulmonary TB Certara2016 年 8 月 10 日